Literature DB >> 12055232

A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery.

Jeff Alexander1, Carla Oseroff, Carol Dahlberg, Mingsheng Qin, Glenn Ishioka, Melanie Beebe, John Fikes, Mark Newman, Robert W Chesnut, Phillip A Morton, Kam Fok, Ettore Appella, Alessandro Sette.   

Abstract

Proteins are generally regarded as ineffective immunogens for CTL responses. We synthesized a 100-mer decaepitope polypeptide and tested its capacity to induce multiple CD8(+) IFN-gamma and Th lymphocyte (HTL) responses in HLA transgenic mice. Following a single immunization in the absence of adjuvant, significant IFN-gamma in vitro recall responses were detected for all epitopes included in the construct (six A2.1-, three A11-restricted CTL epitopes, and one universal HTL epitope). Immunization with truncated forms of the decaepitope polypeptide was used to demonstrate that optimal immunogenicity was associated with a size of at least 30-40 residues (3-4 epitopes). Solubility analyses of the truncated constructs were used to identify a correlation between immunogenicity for IFN-gamma responses and the propensity of these constructs to form particulate aggregates. Although the decaepitope polypeptide and a pool of epitopes emulsified in IFA elicited similar levels of CD8(+) responses using fresh splenocytes, we found that the decaepitope polypeptide more effectively primed for in vitro recall CD8(+) T cell responses. Finally, immunogenicity comparisons were also made between the decaepitope polypeptide and a corresponding gene encoding the same polypeptide delivered by naked DNA immunization. Although naked DNA immunization induced somewhat greater direct ex vivo and in vitro recall responses 2 wk after a single immunization, only the polypeptide induced significant in vitro recall responses 6 wk following the priming immunization. These studies support further evaluation of multiepitope polypeptide vaccines for induction of CD8(+) IFN-gamma and HTL responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055232     DOI: 10.4049/jimmunol.168.12.6189

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201.

Authors:  Hua Cong; Ernest J Mui; William H Witola; John Sidney; Jeff Alexander; Alessandro Sette; Ajesh Maewal; Rima McLeod
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

2.  T-cell recognition of Paracoccidioides brasiliensis gp43-derived peptides in patients with paracoccidioidomycosis and healthy individuals.

Authors:  Leo Kei Iwai; Márcia Yoshida; Aya Sadahiro; Washington Robert da Silva; Maria Lucia Marin; Anna Carla Goldberg; Maria Aparecida Juliano; Luiz Juliano; Maria Aparecida Shikanai-Yasuda; Jorge Kalil; Edecio Cunha-Neto; Luiz R Travassos
Journal:  Clin Vaccine Immunol       Date:  2007-02-28

3.  A melanoma multiepitope polypeptide induces specific CD8+ T-cell response.

Authors:  Adva Levy; Jacob Pitcovski; Shoshana Frankenburg; Orit Elias; Yael Altuvia; Hanna Margalit; Tamar Peretz; Jacob Golenser; Michal Lotem
Journal:  Cell Immunol       Date:  2008-02-13       Impact factor: 4.868

4.  Expression, purification and refolding of a self-assembling protein nanoparticle (SAPN) malaria vaccine.

Authors:  Qin Guo; Debleena Dasgupta; Tais A P F Doll; Peter Burkhard; David E Lanar
Journal:  Methods       Date:  2013-03-30       Impact factor: 3.608

5.  Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii.

Authors:  Hua Cong; Ernest J Mui; William H Witola; John Sidney; Jeff Alexander; Alessandro Sette; Ajesh Maewal; Rima McLeod
Journal:  Immunome Res       Date:  2010-12-03

6.  Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides.

Authors:  Lbachir BenMohamed; Alan Thomas; Pierre Druilhe
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  In silico prediction of peptides binding to multiple HLA-DR molecules accurately identifies immunodominant epitopes from gp43 of Paracoccidioides brasiliensis frequently recognized in primary peripheral blood mononuclear cell responses from sensitized individuals.

Authors:  Leo Kei Iwai; Márcia Yoshida; John Sidney; Maria Aparecida Shikanai-Yasuda; Anna Carla Goldberg; Maria Aparecida Juliano; Jurgen Hammer; Luiz Juliano; Alessandro Sette; Jorge Kalil; Luiz Rodolpho Travassos; Edecio Cunha-Neto
Journal:  Mol Med       Date:  2003 Sep-Dec       Impact factor: 6.354

8.  Immune-tolerant elastin-like polypeptides (iTEPs) and their application as CTL vaccine carriers.

Authors:  S Cho; S Dong; K N Parent; M Chen
Journal:  J Drug Target       Date:  2015-08-25       Impact factor: 5.121

9.  Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.

Authors:  Jianfei Qian; Jin Xie; Sungyoul Hong; Jing Yang; Liang Zhang; Xiaohong Han; Michael Wang; Fenghuang Zhan; John D Shaughnessy; Joshua Epstein; Larry W Kwak; Qing Yi
Journal:  Blood       Date:  2007-05-21       Impact factor: 22.113

10.  Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice.

Authors:  Kamal El Bissati; Ying Zhou; Debleena Dasgupta; Drew Cobb; Jitender P Dubey; Peter Burkhard; David E Lanar; Rima McLeod
Journal:  Vaccine       Date:  2014-04-13       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.